| |
|
|
|
Arca Biopharma Inc  
|
|
4.63 0.02 (0%) |
01-21 13:00 |
|
Open: |
4.63 |
Pre close: |
4.61 |
Target:
|
5.63 
|
|
High: |
4.82 |
Low: |
4.59 |
Resistance:
|
4.82
5.63
|
|
Volume: |
758,380 |
Market Cap: |
43M |
Support:
|
4.29
3.96
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.60
|
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
4.32 |
Signal(12,26,9): |
0.07 |
|
MA(100): |
4.31  |
Stochastic Oscillator |
%K(14,3):
|
85.83 |
|
MA(250): |
4.92 |
%D(3): |
84.15 |
|
Average Volume(K) |
3-Month: |
47004
|
52-Week |
High:
|
22.00 |
|
10-Days: |
60446 |
Low: |
2.21 |
|
RSI |
RSI(14):
|
62.74 |
Change(%): |
-16.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.112 |
Return on Equity (ttm) |
-19.7 |
Shares Out. (M) |
9.32 |
|
EPS Est. Current Year |
-1.750 |
Return on Assets (ttm) |
-11.9 |
Shares Float (M) |
9.28 |
|
EPS Est. Next Year |
-1.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.40 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
8.43 |
|
Forward EPS |
-0.570 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
41 |
|
Book Value (p.s.) |
5.430 |
EBITDA (p.s.) |
-0.634 |
P/E |
-2.23 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.87 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-5.89 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.75 |
P/CF |
-7.44 |
|
|
|
|
|
|
